Ageo, Japan

Naoki Okada

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Toa Eiyo Ltd.. Active years: 2016-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoki Okada. Retrieved from https://idiyas.com/inventor/naoki-okada-x112f09i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Naoki Okada: Innovator in Pharmaceutical Chemistry

Introduction

Naoki Okada is a prominent inventor based in Ageo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative compounds. With a total of 2 patents, Okada continues to push the boundaries of medicinal chemistry.

Latest Patents

Okada's latest patents include a compound known as 4-aminomethylbenzoic acid derivative. This compound is represented by a general formula that includes various substituents, such as aryl groups and C-Calkyl groups. Additionally, he has developed a bicyclic compound that serves as a pharmaceutical agent, showcasing his expertise in creating complex chemical structures.

Career Highlights

Throughout his career, Naoki Okada has been associated with Toa Eiyo Ltd., a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Okada has collaborated with notable coworkers, including Kazuhiro Uemoto and Yoshimichi Sato. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Naoki Okada's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…